UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036203
Receipt number R000041242
Scientific Title Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitis
Date of disclosure of the study information 2019/03/15
Last modified on 2021/07/20 08:39:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitis

Acronym

Identifying high risk patients of colorectal cancer in ulcerative colitis

Scientific Title

Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitis

Scientific Title:Acronym

Identifying high risk patients of colorectal cancer in ulcerative colitis

Region

Japan


Condition

Condition

Ulcerative Colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

DNA methylation analysis in rectal mucosa from ulcerative colitis patients for evaluating the risk of colorectal cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic accuracy of DNA methylation analysis for ulcerative colitis patients complicated with colorectal cancer using rectal mucosa from ulcerative colitis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Longstanding ulcerative colitis patients who need screening colonoscopy

Key exclusion criteria

Ulcerative patients less than 20 years
Ulcerative patients without ability for judgment

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Toiyama

Organization

Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine

Division name

Department of Gastrointestinal and Pediatric Surgery

Zip code

514-8507

Address

2-174 Edobashi Tsu Mie

TEL

059-232-1111

Email

ytoi0725@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name Yuji
Middle name
Last name Toiyama

Organization

Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medic

Division name

Department of Gastrointestinal and Pediatric Surgery

Zip code

514-8507

Address

2-174 Edobashi Tsu Mie

TEL

059-232-1111

Homepage URL


Email

ytoi0725@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mie University Hospital

Address

2-174 Edobashi Tsu Mie

Tel

059-232-1111

Email

ytoi0725@clin.medic.mie-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 03 Month 15 Day

Date of IRB

2018 Year 07 Month 02 Day

Anticipated trial start date

2019 Year 03 Month 15 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2019 Year 03 Month 14 Day

Last modified on

2021 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041242